NYSE$COR

Cencora Inc · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

AmerisourceBergen's revenue increased slightly, with GAAP EPS at $1.41 and adjusted EPS at $1.85.

AmerisourceBergen reported a slight increase in revenue for Q3 2020, with a rise in adjusted diluted EPS. The company raised its adjusted diluted EPS guidance for fiscal year 2020.

  • Revenue increased 0.3 percent year-over-year to $45.4 billion.
  • GAAP diluted EPS was $1.41, compared to $1.43 in the prior year quarter.
  • Adjusted diluted EPS increased 5.1 percent to $1.85.
  • Adjusted diluted EPS guidance for fiscal 2020 raised to a range of $7.80 to $7.95.

Headline financials

Total Revenue

$45.4B

Previous: $45.2B+0.3%
EPS (adj)

$1.85

Previous: $1.76+5.1%
Effective Tax Rate

16.5%

Previous: 18.6%-11.3%
Adj. Effective Tax Rate

18.8%

Previous: 21.0%-10.5%
Capital Expenditures

-$251M

Previous: -$231M-8.8%
Free Cash Flow

$38.3M

Previous: $71.2M-46.1%
Net Income

$289M

Previous: $302M-4.1%
Operating Income

$405M

Previous: $407M-0.5%
Gross Profit

$1.23B

Previous: $1.23B-0.4%
Cash & Equivalents

$3.42B

Previous: $3B+14.0%
Total Assets

$40.8B

Previous: $38.5B+6.0%
Stock-Based Comp

$11.8M

Previous: $10.6M+11.9%

Revenue & EPS history

Cencora · Revenue · Quarterly

$45.4B

Q3 2020+0.3%vs Q3 2019
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Forward guidance

AmerisourceBergen updated its fiscal year 2020 financial guidance to reflect the Company’s continued strong performance and solid execution.

Tailwinds

  • Revenue growth in the mid-single digit percent range, up from the low- to mid- single digit percent range
  • Adjusted Diluted EPS to be in the range of $7.80 to $7.95, up from the previous range of $7.35 to $7.65
  • Adjusted operating income growth in the mid- to high-single digit percent range, up from the low- to mid-single digit percent range
  • Pharmaceutical Distribution Services segment operating income growth in the mid- to high-single digit percent range, up from the low- to mid-single digit percent range
  • Other, which is comprised of businesses focused on Global Commercialization Services & Animal Health, operating income growth in the low-single digit percent range, up from operating income decline in the low-single digit percent rage

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

-0.1%

Avg return

Earnings day

+0.3%

Avg return

5 days after

+1.4%

Avg return

30 days after

48%

35 / 73 earnings

Positive

+7.8%

Q2 2019

Best reaction

-18.4%

Q2 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026-18.4%-16.6%-10.1%
Q1 2026-5.9%+0.4%-0.9%
Q4 2025+2.9%+5.8%-1.4%
Q3 2025-2.9%-0.6%+0.1%
Q2 2025+4.6%-4.3%-0.6%
Q1 2025+0.7%-2.1%+1.2%
Q4 2024+5.9%+6.5%+4.0%
Q3 2024+5.8%+4.4%+3.7%
Q2 2024-6.0%-6.3%-5.2%
Q1 2024+7.4%+6.2%+7.5%
Q4 2023+4.2%+4.7%+9.0%
Q3 2023+1.2%-1.3%-7.5%
Q2 2023+0.1%+0.7%+3.5%
Q1 2023-6.2%-8.6%-7.6%
Q4 2022+4.4%+3.1%+12.4%
Q3 2022-2.5%-1.5%+3.4%
Q2 2022+2.9%+4.4%-2.5%
Q1 2022+0.2%+1.3%+7.0%
Q4 2021-0.6%-2.8%-9.0%
Q3 2021-1.5%-2.8%+1.2%
Q2 2021-6.5%-2.1%-7.1%
Q1 2021+3.9%+1.8%-0.7%
Q4 2020-1.0%+4.8%-1.9%
Q3 2020-3.0%-1.6%-7.7%
Q2 2020+3.0%+3.6%+15.8%
Q1 2020-4.8%-2.0%-6.2%
Q4 2019+1.6%+1.0%+4.2%
Q3 2019+3.8%-3.5%-5.6%
Q2 2019+7.8%+5.5%+6.1%
Q1 2019+6.7%+9.2%+5.7%
Q4 2018-2.3%+0.3%-2.9%
Q3 2018+1.9%+5.0%+13.2%
Q2 2018-4.3%-5.1%-6.6%
Q1 2018+2.5%-2.9%+4.7%
Q4 2017-2.4%-2.2%+10.9%
Q3 2017-11.4%-12.0%-12.1%
Q2 2017+3.9%+5.9%+13.2%
Q1 2017+6.0%+6.8%+9.9%
Q4 2016+3.6%+3.1%+12.9%
Q3 2016+5.1%+4.5%+1.9%
Q2 2016-9.2%
Q1 2016-3.7%
Q4 2015-1.0%
Q3 2015-5.4%
Q2 2015+1.9%
Q1 2015+0.4%
Q4 2014+7.1%
Q3 2014+3.7%
Q2 2014-3.1%
Q1 2014-4.3%
Q4 2013+1.8%
Q3 2013-0.0%
Q2 2013-4.6%
Q1 2013-5.1%
Q4 2012-0.6%
Q3 2012+2.7%
Q2 2012-1.2%
Q1 2012+2.4%
Q4 2011-1.0%
Q3 2011-0.5%
Q2 2011+2.9%
Q1 2011+0.5%
Q4 2010-0.5%
Q3 2010-0.7%
Q2 2010+1.0%
Q1 2009-1.7%
Q1 2010+1.2%
Q4 2009-0.6%
Q2 2009-0.6%
Q4 2007-0.6%
Q3 2008-0.5%
Q3 2009-0.5%
Q4 2008-0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro